Needham & Company Starts BioTelemetry (BEAT) at Buy

September 11, 2020 6:23 AM EDT
Get Alerts BEAT Hot Sheet
Price: $0.59 +3.51%

Rating Summary:
    8 Buy, 7 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 9
Join SI Premium – FREE

Needham & Company analyst Mike Matson initiates coverage on BioTelemetry (NASDAQ: BEAT) with a Buy rating and a price target of $52.00.


For an analyst ratings summary and ratings history on BioTelemetry click here. For more ratings news on BioTelemetry click here.


Shares of BioTelemetry closed at $36.67 yesterday.


You May Also Be Interested In





Related Categories

Hot New Coverage, New Coverage